Predictive Oncology Past Earnings Performance

Past criteria checks 0/6

Predictive Oncology's earnings have been declining at an average annual rate of -3.9%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 7.1% per year.

Key information

-3.9%

Earnings growth rate

65.0%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate7.1%
Return on equity-364.6%
Net Margin-754.2%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Predictive Oncology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

MUN:S1K Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 242-15160
31 Dec 232-14150
30 Sep 232-18160
30 Jun 232-19170
31 Mar 231-26160
31 Dec 222-26160
30 Sep 222-26160
30 Jun 221-27150
31 Mar 221-19140
31 Dec 211-20140
30 Sep 211-23130
30 Jun 211-25130
31 Mar 211-26140
31 Dec 201-26130
30 Sep 201-29130
30 Jun 201-26140
31 Mar 201-21150
31 Dec 191-20140
30 Sep 191-9150
30 Jun 191-8130
31 Mar 191-1290
31 Dec 181-1090
30 Sep 181-870
30 Jun 181-660
31 Mar 181-670
31 Dec 171-670
30 Sep 171-660
30 Jun 171-660
31 Mar 171-650
31 Dec 160-760
30 Sep 161-870
30 Jun 160-870
31 Mar 161-770
31 Dec 151-550
30 Sep 151-550
30 Jun 151-550
31 Mar 151-560
31 Dec 141-770
30 Sep 141-770
30 Jun 141-990
31 Mar 140-990
31 Dec 130-990
30 Sep 130-980

Quality Earnings: S1K is currently unprofitable.

Growing Profit Margin: S1K is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: S1K is unprofitable, and losses have increased over the past 5 years at a rate of 3.9% per year.

Accelerating Growth: Unable to compare S1K's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: S1K is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).


Return on Equity

High ROE: S1K has a negative Return on Equity (-364.63%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.